Vancouver, BC -- (SBWIRE) -- 02/09/2021 -- Recurrent Atrial Fibrillation Market

The recurrent atrial fibrillation market is set to attain a valuation of USD 25.93 Billion by 2027, registering a CAGR of 13.2%. Atrial fibrillation (AFib) is a heart disorder characterized by irregular or fast-paced heart rate. Recurrent atrial fibrillation is defined as an atrial arrhythmia episode that occurs after the first three months after the cardiac ablation procedure and lasts for more than 30 seconds. The growing incidences of obesity, elevated blood pressure, family history, and stress, among others, are increasing the rate of recurrent atrial fibrillation.

Get your Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample/71

Prominent Players Profiled in the Recurrent Atrial Fibrillation Market:

Abbott Laboratories, Atricure Inc., Johnson & Johnson, Microport Scientific Corporation, Boston Scientific Corporation, Biosense Webster, Inc., St. Jude medical, Inc., Siemens AG, Medtronic Plc, Koninklijke Philips N.V., AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, and GlaxoSmithKline

Market Drivers

The major driving force for the development of the recurrent atrial fibrillation market is increasing reimbursement options for recurrent AFib medications, new medication releases for successful treatment, and the occurrence of recurrent atrial fibrillation, coupled with technological developments.

Product Outlook (Revenue, USD Billion; 2017-2027)
Device
Surgical Devices
Maze Surgery
Catheter Ablation
Radiofrequency Catheter Ablation
Conventional RF Ablation Catheters
Irrigated-tip RF Ablation Catheters
Cryoablation
Microwave Based Catheter Ablation
Laser Based Catheter Ablation
Navigational Advanced Mapping Accessories
Non-Surgical Devices
Electric Cardioversion
EP Ablation Catheters
EP Diagnostic Catheter
Conventional Diagnostic Catheters
Fixed Diagnostic Catheters
Steerable Diagnostic Catheters
Advanced Diagnostic Catheters
Mapping and Recording Systems
Cardiac Monitors or Loop Recorders
Access Devices
Left Atrial Appendage and Closure Devices
Intracardiac Echocardiography (ICE) Systems
Drugs
Dabigatran (Pradaxa)
Rivaroxaban (Xarelto)
Apixaban (Eliquis)
Edoxaban (Savaysa)
Warfarin (Coumadin)
Others

Application Outlook (Revenue, USD Billion; 2017-2027)
EP Ablation
Diagnostic
Surgical Cardiac

End Users Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
Cardiac Centers
Ambulatory Care Centers

ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/71

Overview of the TOC of the Report:

Introduction, Scope, and Overview
Opportunities, Risks, and Drivers
Competition landscape analysis with sales, revenue, and price
Extensive Profiling of the key competitors with the sales figures, revenue, and market share
Regional analysis with sales, revenue, and market share for each region for the forecast period
Country-wise analysis of the Recurrent Atrial Fibrillation market by type, application, and manufacturers
Market Segmentation based on types
Market segmentation based on applications
Historical and forecast estimation and other chapters.

Regional Analysis

In 2019, the North America region accounted for USD 4.04 billion market share due to the high prevalence of recurrent atrial fibrillation in Canada and the U.S. North America holds the highest market share with a CAGR of 13.1%. The incidence rate of surgical procedures has increased in the U.S. gradually. Disease prevailing dietary behaviors and eating habits have led to an increase in Atrial Fibrillation in the region.

Asia Pacific region significant share in the recurrent atrial fibrillation market over the forecast period. The region is projected to expand fastest due to powerful infrastructural improvements in the healthcare sector, increasing technological advancements, and growing research and development initiatives.

In 2019, the Europe region accounted for USD 2.77 billion market share and is expected to grow substantially over the forecast period. The regional market is driven by the rising demand for radiofrequency catheter ablation and microwave devices coupled with the government of EU nations' increasing initiatives for the control, prevention, and diagnosis of a substantial increase in disabling strokes.

Take a Look at our Related Reports:

Activated Carbon Market Development Strategy

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Future Growth

Neurostimulation Devices Market Research Methodology

Signal Intelligence (SIGINT) Market Drivers

Sodium Dichromate Market Manufacturers

Industrial Microbiology Market Revenue

Surgical Instrument Tracking Systems Market Size

Medical Lighting Technologies Market Share

Smart Irrigation Controllers Market Trends

Soldier System Market Growth

Plant-Based Food & Beverage Alternatives Market Analysis

Nano Drones Market Business Opportunities

Fermented Food and Ingredients Market Key Players

Mobile Robot Market Demand

Forensic Technology Market Competitive Landscape

Autonomous Delivery Vehicles Market Segments

Solid Waste Management Market Overview

Prenatal Testing Industry

Digital Biomarkers Market Statistics

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs